Keywords: canadian, rx, spending, slows, pmprb, human-use, drug
Canadian Rx spending slows in 2004: PMPRB
Article | 27 June 2005
Total human-use drug sales in Canada rose 5.3% to C$15.9 billion ($12.85 billion) in 2004, while patented products were up 7.9% to $10.9 billion, which ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
